{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:50:01Z","timestamp":1790909401767,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.prp.2025.156136","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:06:58Z","timestamp":1752793618000},"page":"156136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The unexplored Nexus: Mitochondria derived microproteins and Parkinson\u2019s disease"],"prefix":"10.1016","volume":"273","author":[{"given":"Kashish","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156136_bib1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cortex.2008.11.010","article-title":"Parkinson\u2019s disease: the syndrome, the pathogenesis and pathophysiology","volume":"45","author":"Bartels","year":"2009","journal-title":"Cortex"},{"key":"10.1016\/j.prp.2025.156136_bib2","series-title":"in: Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects","first-page":"3","article-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018"},{"key":"10.1016\/j.prp.2025.156136_bib3","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/acschemneuro.3c00084","article-title":"Uncovering novel therapeutic targets for Parkinson\u2019s disease","volume":"14","author":"Soni","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.prp.2025.156136_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1021\/acschemneuro.2c00165","article-title":"Deciphering intertwined molecular pathways underlying metabolic syndrome leading to Parkinson\u2019s disease","volume":"13","author":"Soni","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.prp.2025.156136_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102208","article-title":"An update on new-age potential biomarkers for Parkinson\u2019s disease","volume":"94","author":"Soni","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.prp.2025.156136_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.prp.2025.156136_bib7","first-page":"1","article-title":"Disease burden of Parkinson\u2019s Disease in Asia and Its 34 countries and territories from 1990 to 2021: findings from the global burden of disease study 2021","author":"Yang","year":"2024","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.prp.2025.156136_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.prp.2025.156136_bib9","doi-asserted-by":"crossref","unstructured":"D.K. Simon, C.M. Tanner, P. Brundin, Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology, 2019.","DOI":"10.1016\/j.cger.2019.08.002"},{"key":"10.1016\/j.prp.2025.156136_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.156136_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mdc3.12568","article-title":"Epidemiology of Parkinson\u2019s disease\u2014East versus West","volume":"5","author":"Abbas","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.prp.2025.156136_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.prp.2025.156136_bib13","first-page":"1","article-title":"MitochondriaL Dysfunction and \u03b1-Synuclein Synaptic Pathology in Parkinson\u2019s disease: who\u2019s on first?","volume":"2015","author":"Zaltieri","year":"2015","journal-title":"Park. Dis."},{"key":"10.1016\/j.prp.2025.156136_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156136_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","article-title":"A critical evaluation of current staging of \u03b1-synuclein pathology in Lewy body disorders","volume":"1792","author":"Jellinger","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.prp.2025.156136_bib16","doi-asserted-by":"crossref","first-page":"8517","DOI":"10.1523\/JNEUROSCI.1806-08.2008","article-title":"Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response","volume":"28","author":"Lee","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2025.156136_bib17","doi-asserted-by":"crossref","first-page":"S838","DOI":"10.1093\/geroni\/igz038.3088","article-title":"Mitochondrial-derived peptide, SHLP2, a novel protective factor in Parkinson\u2019s disease","volume":"3","author":"Kim","year":"2019","journal-title":"Innov. Aging"},{"key":"10.1016\/j.prp.2025.156136_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s11357-020-00262-5","article-title":"Mitochondrial-derived peptides in aging and age-related diseases","volume":"43","author":"Kim","year":"2021","journal-title":"Geroscience"},{"key":"10.1016\/j.prp.2025.156136_bib19","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1152\/ajpendo.00249.2020","article-title":"Mitochondrial-derived peptides in energy metabolism","volume":"319","author":"Merry","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156136_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10989-023-10558-7","article-title":"A review on mitochondrial derived peptide humanin and small humanin-like peptides and their therapeutic strategies","volume":"29","author":"Thamarai Kannan","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.prp.2025.156136_bib21","article-title":"Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition","volume":"1866","author":"Thiankhaw","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) Gen. Subj."},{"key":"10.1016\/j.prp.2025.156136_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-025-05098-8","article-title":"The effect of metformin on astrocytes in parkinson\u2019s disease: challenges and opportunities","author":"Al-kuraishy","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156136_bib23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10787-023-01400-z","article-title":"The effects of cholesterol and statins on Parkinson\u2019s neuropathology: a narrative review","volume":"32","author":"Al-kuraishy","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.prp.2025.156136_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140789","article-title":"Unveiling the significance of synaptic proteins in parkinson\u2019s pathogenesis: a review","volume":"304","author":"Soni","year":"2025","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.prp.2025.156136_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/apjtb.apjtb_229_24","article-title":"C-phycocyanin shows neuroprotective effect against rotenone-induced Parkinson\u2019s disease in mice","volume":"14","author":"Rathod","year":"2024","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.prp.2025.156136_bib26","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.4c00586","article-title":"Hyperglycemia-driven insulin signaling defects promote parkinson\u2019s disease-like pathology in mice","author":"Soni","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.prp.2025.156136_bib27","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.5c00112","article-title":"Upregulation of the PI3K\/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson\u2019s Disease Mouse Models","author":"Soni","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.prp.2025.156136_bib28","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.4c00729","article-title":"Dual GLP-1 and GIP agonist tirzepatide exerted neuroprotective action in a Parkinson\u2019s disease rat model","author":"Delvadia","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.prp.2025.156136_bib29","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1007\/s12035-022-03005-z","article-title":"Chlorogenic acid: a polyphenol from coffee rendered neuroprotection against rotenone-induced Parkinson\u2019s Disease by GLP-1 secretion","volume":"59","author":"Sharma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2025.156136_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.prp.2025.156136_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2741\/3628","article-title":"DNA induced folding\/fibrillation of alpha-synuclein: new insights in Parkinson\u2019s disease","volume":"15","author":"Hegde","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.prp.2025.156136_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0349-x","article-title":"Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway","volume":"15","author":"Park","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.prp.2025.156136_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.arr.2017.09.006","article-title":"Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson\u2019s disease. An integrated strategy for management","volume":"40","author":"Phillipson","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.prp.2025.156136_bib34","article-title":"Biomarker of neuroinflammation in Parkinson\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156136_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in parkinson\u2019s disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.prp.2025.156136_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.prp.2025.156136_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.prp.2025.156136_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12291-009-0017-y","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"24","author":"Nikam","year":"2009","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.prp.2025.156136_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.prp.2025.156136_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbadis.2009.09.003","article-title":"Mitochondria, oxidative metabolism and cell death in stroke","volume":"1802","author":"Sims","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.prp.2025.156136_bib41","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson\u2019s disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.prp.2025.156136_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson\u2019s disease","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.prp.2025.156136_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158449","article-title":"Mitochondria-derived peptides in aging and healthspan","volume":"132","author":"Miller","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2025.156136_bib44","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","article-title":"Mitochondria-associated programmed cell death as a therapeutic target for age-related disease","volume":"55","author":"Nguyen","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.prp.2025.156136_bib45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0344-0338(85)80223-5","article-title":"Book Reviews","volume":"179","author":"Schr\u00f6der","year":"1985","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156136_bib46","article-title":"Involvement of antioxidant enzymes in Parkinson\u2019s disease","volume":"249","author":"Tahavvori","year":"2023","journal-title":"Pathol. Res. Pr."},{"key":"10.1016\/j.prp.2025.156136_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155605","article-title":"Environmental pollutants and alpha-synuclein toxicity in Parkinson\u2019s disease","volume":"263","author":"Roy","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156136_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156077","article-title":"Autophagy in disease management: exploring the potential of natural products as targeted therapies","volume":"272","author":"Eissa","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156136_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156013","article-title":"Recent advances in stem cell approaches to neurodegeneration: a comprehensive review with mechanistic insight","volume":"271","author":"Begh","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156136_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155985","article-title":"The critical role of GLP-1 signaling pathways in the pathology of Parkinson\u2019s disease and diabetes","volume":"270","author":"Chen","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156136_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-023-03885-2","article-title":"Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging","volume":"21","author":"Wan","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2025.156136_bib52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/biology12040558","article-title":"Humanin and Its pathophysiological roles in aging: a systematic review","volume":"12","author":"Coradduzza","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.prp.2025.156136_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2014.00210","article-title":"Humanin and age-related diseases: a new link?","volume":"5","author":"Gong","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156136_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33290-5","article-title":"Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration","volume":"8","author":"Nashine","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156136_bib55","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/s41467-023-40082-7","article-title":"Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons","volume":"14","author":"Kim","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156136_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41053-0","article-title":"Evidence of natural selection in the mitochondrial-derived peptides humanin and SHLP6","volume":"13","author":"Gruschus","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156136_bib57","doi-asserted-by":"crossref","first-page":"796","DOI":"10.18632\/aging.100943","article-title":"Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers","volume":"8","author":"Cobb","year":"2016","journal-title":"Aging"},{"key":"10.1016\/j.prp.2025.156136_bib58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41380-023-02344-0","article-title":"A naturally occurring variant of SHLP2 is a protective factor in Parkinson\u2019s disease","volume":"29","author":"Kim","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.prp.2025.156136_bib59","article-title":"Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition","volume":"1866","author":"Thiankhaw","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) Gen. Subj."},{"key":"10.1016\/j.prp.2025.156136_bib60","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.44763","article-title":"Exploring the potential of antidiabetic agents as therapeutic approaches for Alzheimer\u2019s and Parkinson\u2019s diseases: a comprehensive review","author":"Koshatwar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.prp.2025.156136_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.72","article-title":"Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson\u2019s disease","volume":"7","author":"Lehmann","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2025.156136_bib62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.prp.2025.156136_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2025.156136_bib64","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4103\/1673-5374.215251","article-title":"SLP-2: a potential new target for improving mitochondrial function in Parkinson\u2019s disease","volume":"12","author":"Zanon","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.prp.2025.156136_bib65","article-title":"Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson\u2019s disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2025.156136_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4161\/pri.20026","article-title":"The role of Bax and caspase-3 in doppel-induced apoptosis of cerebellar granule cells","volume":"6","author":"Didonna","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.prp.2025.156136_bib67","doi-asserted-by":"crossref","unstructured":"D. Kazyken, S.G. Dame, C. Wang, M. Wadley, D.C. Fingar, Unexpected roles for AMPK in the suppression of autophagy and the reactivation of mTORC1 signaling during prolonged amino acid deprivation, (2023). https:\/\/doi.org\/10.1101\/2023.12.20.572593.","DOI":"10.1101\/2023.12.20.572593"},{"key":"10.1016\/j.prp.2025.156136_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/MCB.06159-11","article-title":"Role of AMPK-mTOR-Ulk1\/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks","volume":"32","author":"Alers","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.prp.2025.156136_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/NRR.NRR-D-23-01195","article-title":"The autophagy\u2013lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson\u2019s disease","volume":"20","author":"Jiao","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.prp.2025.156136_bib70","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","article-title":"NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson\u2019s disease","volume":"39","author":"Han","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.prp.2025.156136_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00073","article-title":"The potential role of the NLRP3 inflammasome activation as a link between mitochondria ROS generation and neuroinflammation in postoperative cognitive dysfunction","volume":"13","author":"Wei","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.prp.2025.156136_bib72","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/JME-12-0203","article-title":"The emerging role of the mitochondrial-derived peptide humanin in stress resistance","volume":"50","author":"Yen","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.prp.2025.156136_bib73","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/biology12121534","article-title":"Neuroprotective action of humanin and humanin analogues: research findings and perspectives","volume":"12","author":"Karachaliou","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.prp.2025.156136_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15280\/jlm.2021.11.1.13","article-title":"Expression profile of mouse Gm20594, nuclear-encoded humanin-like gene","volume":"11","author":"Kim","year":"2021","journal-title":"J. Lifestyle Med."},{"key":"10.1016\/j.prp.2025.156136_bib75","article-title":"The molecular structure and role of humanin in neural and skeletal diseases, and in tissue regeneration","volume":"10","author":"Zhu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2025.156136_bib76","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2018.06.008","article-title":"The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress","volume":"28","author":"Kim","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2025.156136_bib77","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells9051102","article-title":"Effects of mitochondrial-derived peptides (mdps) on mitochondrial and cellular health in AMD","volume":"9","author":"Nashine","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156136_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1120533","article-title":"MOTS-c: a promising mitochondrial-derived peptide for therapeutic exploitation","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2025.156136_bib79","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41467-020-20790-0","article-title":"MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis","volume":"12","author":"Reynolds","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T14:24:41Z","timestamp":1755095081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825003292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":79,"alternative-id":["S0344033825003292"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156136","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The unexplored Nexus: Mitochondria derived microproteins and Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156136"}}